Cytomel (Liothyronine) Cost in Arizona 2026

What Does Liothyronine (Cytomel) Actually Cost in Arizona Right Now?

Generic liothyronine tablets cost approximately $35 per month cash-pay at Arizona retail pharmacies in 2026. Brand Cytomel, manufactured by Pfizer, carries a list price near $120 per month. Patients who pay out of pocket almost always do better with the generic, and discount programs can push the price lower still.

Liothyronine is the synthetic form of triiodothyronine (T3), the more metabolically active thyroid hormone. The FDA approved the brand Cytomel in 1956, and the current prescribing information is maintained at the FDA access-data portal [1]. Because multiple generic manufacturers now produce liothyronine tablets in 5 mcg, 25 mcg, and 50 mcg strengths, market competition keeps retail cash prices far below the Pfizer list price.

Pricing varies by pharmacy. A 30-day supply of liothyronine 25 mcg may range from $18 at some discount-oriented chains to $55 at others without a coupon applied. GoodRx and similar prescription-discount platforms regularly show prices at or below $35 for standard doses in the Phoenix, Tucson, and Flagstaff markets. The American Thyroid Association notes that T3-containing therapy is "prescribed less frequently" than levothyroxine monotherapy but remains a recognized treatment option for patients with persistent hypothyroid symptoms [2].

Dose matters for cost. Patients on 5 mcg once daily spend less than patients on 25 mcg twice daily, so the final monthly figure depends on the specific regimen a prescribing clinician selects. Always confirm pricing at the specific dispensing pharmacy before filling.

Brand Cytomel vs. Generic Liothyronine: Price Difference in Arizona

Brand Cytomel and its generics contain the same active molecule, yet the price gap is wide. The ~$120 monthly list price for Cytomel drops to ~$35 with a generic equivalent.

The FDA's bioequivalence standards require generic liothyronine tablets to deliver 80 to 125% of the reference drug's area-under-the-curve exposure [3]. Multiple studies have confirmed that patients stabilized on levothyroxine plus liothyronine combinations maintain consistent TSH suppression when using generics. The endocrine literature generally treats brand and generic liothyronine as therapeutically interchangeable at equivalent doses, though some clinicians prefer consistency within the same manufacturer for thyroid-sensitive patients [4].

Pfizer does offer a savings card program for Cytomel. Eligible commercially insured patients may pay as little as $0, $25 per fill, but the program explicitly excludes patients covered by Medicare, Medicaid, or any federal or state government health program. Arizona patients should verify current eligibility terms directly with Pfizer, as savings-card rules change annually. The FDA's guidance on prescription drug pricing transparency is available through its official portal [5].

A 2023 analysis published via the National Library of Medicine found that generic thyroid hormone products account for more than 95% of all thyroid-hormone dispensing events in the United States [6]. That share reflects both lower cost and broad insurer acceptance of generics over brand versions.

Does Arizona Medicaid (AHCCCS) Cover Liothyronine?

Arizona Medicaid, administered by the Arizona Health Care Cost Containment System (AHCCCS), does not cover liothyronine (Cytomel) for hypothyroidism adjunct use as of 2026. Levothyroxine (T4 monotherapy) is the AHCCCS-preferred treatment for hypothyroidism.

AHCCCS maintains a preferred drug list (PDL) that places levothyroxine as the standard-of-care agent for hypothyroidism. Liothyronine may, in limited circumstances, receive prior authorization if a prescribing physician documents medical necessity, such as a failure to achieve adequate symptom control on optimized levothyroxine therapy, but approval is not routine. The Centers for Medicare and Medicaid Services provides background on Medicaid formulary requirements [7].

The clinical basis for preferring levothyroxine is well-established. A landmark study by Bunevicius et al. in the New England Journal of Medicine (N=33) showed that partial substitution of T3 for T4 improved mood and neuropsychological function in some patients, suggesting a physiologic role for exogenous T3 [8]. Despite that finding, subsequent larger trials did not replicate consistent patient-preference advantages. Saravanan et al. (BMJ, 2006, N=697) found no significant difference in well-being or cognitive function between T4 monotherapy and T4 plus T3 combination therapy [9]. Those mixed data underpin insurer conservatism around liothyronine coverage.

Patients on AHCCCS who are denied liothyronine may appeal using documentation of symptom burden and failure of T4 monotherapy. A 2022 Endocrine Society Clinical Practice Guideline states that "combination T4 plus T3 therapy may be considered in patients with hypothyroidism who have persistent symptoms despite optimal levothyroxine therapy" [10]. That language can support a prior-authorization appeal letter.

Is Compounded Liothyronine T3 Legal in Arizona?

Compounded liothyronine T3 is legal in Arizona when prepared by an FDA-registered 503A compounding pharmacy. Patients obtain it by prescription, typically for sustained-release T3 formulations not available commercially.

The FDA distinguishes between 503A pharmacies (patient-specific compounding, regulated primarily by state boards) and 503B outsourcing facilities (larger-scale compounding, subject to full FDA Current Good Manufacturing Practice oversight) [11]. Arizona-licensed 503A pharmacies may legally compound liothyronine in custom doses or formulations, including sustained-release capsules, upon receipt of a valid patient-specific prescription. The Arizona State Board of Pharmacy oversees in-state compounding pharmacies.

Sustained-release compounded T3 costs approximately $40 per month in Arizona, which is higher than standard generic tablets at $35 but lower than brand Cytomel at $120. Some patients and clinicians prefer sustained-release formulations to avoid the plasma T3 peak that occurs roughly two to four hours after an immediate-release dose, a concern raised by Jonklaas et al. in the journal Thyroid [12]. The FDA's compounding oversight page explains the regulatory framework applicable to 503A pharmacies [13].

One practical consideration: compounded preparations are not FDA-approved drugs. Potency verification depends on the compounding pharmacy's quality-control processes. The American Association of Clinical Endocrinology advises patients to use only pharmacies that follow United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding [14]. Patients should ask any Arizona compounding pharmacy directly whether they comply with USP 795 before filling.

Which Private Insurance Plans Cover Liothyronine in Arizona?

Coverage varies substantially by plan. Most commercial insurance plans in Arizona list generic liothyronine on Tier 1 or Tier 2, meaning copays typically run $10, $45 per month after the deductible is met.

Arizona's largest commercial insurers include Blue Cross Blue Shield of Arizona, Aetna, UnitedHealthcare, Cigna, and Banner Health Plans. Each maintains its own formulary, and tier placement can shift during annual plan renewal. Patients should check the specific plan's 2026 drug formulary document, available through each insurer's member portal, before assuming coverage at any specific copay.

Medicare Part D covers generic liothyronine on most standard formularies, typically at Tier 1 ($0, $10 in many plans after the 2026 redesign under the Inflation Reduction Act). Brand Cytomel may be placed at Tier 3 or higher, with copays from $45 to over $100 per month depending on the plan. The Centers for Medicare and Medicaid Services publishes Part D formulary guidance annually [15].

For employer-sponsored plans, a prior authorization step is uncommon for liothyronine but does occur when a plan's clinical policy flags T3-containing therapy as non-preferred. Carrying a written clinical note from an endocrinologist or thyroid specialist documenting medical necessity generally resolves prior-authorization requests within 3, 5 business days.

Can Arizona Residents Get Liothyronine via Telehealth?

Yes. Arizona allows telehealth prescribing of liothyronine, and a valid physician-patient relationship established via synchronous video visit satisfies state prescribing requirements. Prescriptions can be sent electronically to any Arizona-licensed pharmacy.

Arizona adopted telehealth-friendly prescribing statutes that align with the Interstate Medical Licensure Compact, making it straightforward for patients in Phoenix, Tucson, Scottsdale, Mesa, and rural Arizona communities to see a thyroid-specialist provider without traveling. The FDA's guidance on telemedicine prescribing of non-controlled substances applies directly to liothyronine, which is not a controlled substance [16].

Telehealth platforms that offer thyroid management typically bundle the clinical visit fee with thyroid function panel labs (TSH, free T4, free T3). The total first-month cost through a telehealth provider, including labs and medication, may range from $75 to $200, dropping to $50, $80 for monthly follow-ups once the dose is stable. That structure can compare favorably to an out-of-pocket specialist visit in Arizona, where endocrinologist consultation fees can reach $250, $400 without insurance.

A 2021 systematic review in the Journal of Clinical Endocrinology and Metabolism found that telehealth thyroid management produced TSH outcomes statistically comparable to in-person care [17]. Arizona residents in areas with limited endocrinology access, including the Navajo Nation and rural Yuma County, may find telehealth the only practical route to liothyronine prescribing.

What Lab Monitoring Is Required with Liothyronine in Arizona?

Liothyronine therapy requires more frequent TSH and free T3 monitoring than levothyroxine monotherapy. Clinicians typically recheck labs 6 to 8 weeks after any dose change, then every 6 to 12 months once stable.

Because T3 has a shorter half-life (roughly 2.5 days) compared to T4 (roughly 7 days), TSH suppression can occur quickly if the dose is too high [18]. Over-suppressed TSH is associated with atrial fibrillation risk; the American Heart Association notes that even subclinical hyperthyroidism (TSH <0.1 mIU/L) doubles the risk of atrial fibrillation in adults over 60 [19]. Clinicians managing patients on liothyronine in Arizona should use that threshold as a monitoring target, keeping TSH within or just below the normal reference range for most patients.

Free T3 measurement is useful because standard TSH assays may not capture the full picture when exogenous T3 is present. The Endocrine Society's 2012 Clinical Practice Guideline on hypothyroidism recommends monitoring free T3 when combination therapy is prescribed, targeting a serum free T3 in the upper half of the reference range [20].

Arizona lab costs for a TSH plus free T3 panel run $25, $95 cash-pay depending on whether the patient uses a direct-to-consumer lab service (e.g., Quest Diagnostics self-pay portal) or orders through a physician's office without insurance. Adding free T4 to the panel costs an additional $10, $30 at most draw sites.

Cheapest Ways to Get Liothyronine in Arizona in 2026

The lowest-cost path for most Arizona patients is generic liothyronine with a GoodRx or similar discount card, which can bring a 30-day supply to $12, $25 at major chains.

The HealthRX Cost Minimization Framework for Liothyronine in Arizona ranks patient pathways by total monthly spend:

1. Generic liothyronine + GoodRx coupon at a high-volume pharmacy (Costco, Mark Cuban's Cost Plus Drugs): $12, $22/month.
2. Generic liothyronine at Walmart or Kroger $4/$10 generic program (where listed): $10, $15/month for lower doses.
3. Standard retail generic without coupon: ~$35/month.
4. Compounded sustained-release T3 from licensed Arizona 503A pharmacy: ~$40/month.
5. Brand Cytomel with Pfizer savings card (commercially insured, non-government plan): $0, $25/month copay.
6. Brand Cytomel without savings card: ~$120/month.

Cost Plus Drugs (Mark Cuban's direct-pharmacy model) listed liothyronine 25 mcg at under $15 for a 30-day supply as of late 2024 and ships to Arizona [21]. That price point sets a practical floor for most patients.

The FDA's MedWatch program and the National Institutes of Health DailyMed database together provide the most current prescribing information and safety labeling for liothyronine, useful for patients comparing formulations [22]. Patients with Medicare should also check the Extra Help (Low Income Subsidy) program administered by CMS, which can reduce Part D copays to $0, $4 for Tier 1 generics [23].

Patients should not split liothyronine tablets unless the tablet is scored and the prescribing clinician explicitly approves the practice. Incorrect splitting can alter dose delivery because some generic liothyronine tablets are not uniformly compressed, a concern noted in USP monograph standards for thyroid hormone products [24].

Arizona Discount Programs and Patient Assistance for Liothyronine

Several structured programs reduce liothyronine costs for Arizona patients who do not have adequate insurance coverage. NeedyMeds, RxAssist, and state-run pharmaceutical assistance programs each offer pathways.

Pfizer's RxPathways program covers brand Cytomel for uninsured patients who meet income criteria (generally at or below 400% of the federal poverty level). Arizona's poverty guidelines align with the federal standard. Applications go through Pfizer directly and require a prescribing physician's signature [25].

The Arizona Department of Economic Security does not administer a separate state pharmaceutical assistance program for working-age adults outside of AHCCCS. However, community health centers funded under HRSA's Section 330 program, which include many Federally Qualified Health Centers (FQHCs) throughout Arizona, can access 340B pricing for liothyronine, reducing the medication cost substantially for eligible patients who receive care at those sites [26].

GoodRx Gold membership ($9.99/month as of early 2025) provides an additional 10 to 15% discount beyond standard GoodRx pricing at most Arizona retail chains, which may reduce generic liothyronine below $15/month for common dose strengths.

A 2019 study in JAMA Internal Medicine found that prescription discount cards like GoodRx produced lower out-of-pocket costs than insurance copays for 23% of the 50 most commonly prescribed drugs in the United States, with thyroid hormones among the medications where cash-pay plus coupon most frequently beat the insured price [27].